查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1869660

神经刺激设备市场规模、份额和趋势分析报告：按产品、应用、最终用途、地区和细分市场预测（2025-2033 年）

Neurostimulation Devices Market Size, Share & Trends Analysis Report By Product, By Applications, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

神经刺激设备市场摘要

2024年全球神经刺激设备市场规模估计为58亿美元，预计2033年将达到139.3亿美元。

预计从 2025 年到 2033 年，该市场将以 10.29% 的复合年增长率成长。市场成长归因于神经系统疾病盛行率的上升、对微创疗法的偏好增加以及对长期疼痛管理解决方案的需求增加。

闭合迴路刺激、MRI相容设备以及电池续航力的提升等技术进步，提高了治疗的精准度和患者疗效，促进了神经刺激疗法在临床上的广泛应用。此外，神经刺激疗法在慢性疼痛、癫痫、帕金森氏症、忧郁症、脊髓损伤等疾病中的适应症不断扩大，加之许多地区出台了支持性的医疗政策，进一步推动了市场成长。

政府投入的增加是神经刺激设备市场发展的关键驱动力，加速了先进神经刺激技术的研发，并扩大了其治疗应用范围。政府对研究计画、临床试验和创新倡议的资助，有助于加深对神经系统疾病的了解，并支持神经刺激治疗方法的突破。这种资金支持促进了研究人员、临床医生和医疗设备开发商之间的合作，有助于将安全性更高、更精准、更疗效的新一代系统推向市场。此外，旨在改善医疗服务可近性和降低神经系统疾病治疗成本的政府倡议，也间接促进了神经刺激疗法的应用，使其惠及更广泛的患者群体，从而推动了整体市场成长。

目录

第一章调查方法和范围

第二章执行摘要

第三章神经刺激设备市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 神经刺激设备市场分析工具
    • 波特五力分析
    • PESTEL 分析

第四章神经刺激设备市场：依产品分類的估算与趋势分析

  • 细分仪表板
  • 全球神经刺激设备市场：按产品分類的变化分析（2024 年和 2033 年）
  • 全球神经刺激设备市场规模及产品趋势分析（2021-2033年）
  • 脊髓刺激设备
  • 深层脑部刺激器
  • 荐骨神经刺激器
  • 迷走神经刺激设备
  • 胃电刺激
  • 其他的

第五章神经刺激设备市场：按应用分類的估算与趋势分析

  • 细分仪表板
  • 全球神经刺激设备市场：按应用领域分類的变化分析（2024 年和 2033 年）
  • 全球神经刺激设备市场规模及应用趋势分析（2021-2033年）
  • 帕金森氏症
  • 慢性疼痛
  • 偏头痛
  • 癫痫
  • 震颤
  • 忧郁症
  • 尿失禁/粪便失禁
  • 其他的

第六章神经刺激设备市场：依最终用途分類的估算与趋势分析

  • 细分仪表板
  • 全球神经刺激设备市场：按最终用途分類的变化分析（2024 年和 2033 年）
  • 全球神经刺激设备市场规模及趋势分析（依最终用途划分，2021-2033年）
  • 医院和门诊手术中心（ASC）
  • 诊所/物理治疗中心
  • 其他的

第七章神经刺激设备市场：区域估算与趋势分析

  • 区域仪錶板
  • 市场规模及趋势分析，2021-2033年
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 2023年企业市占率分析
  • 公司热力图分析
  • 策略规划
    • 扩张
    • 併购
    • 伙伴关係与合作
    • 新产品发布
    • 研究与开发
    • 公司简介
    • Abbott (St. Jude Medical)
    • Medtronic
    • Boston Scientific Corporation
    • Aleva Neurotherapeutics
    • Nexstim
    • LivaNova PLC
    • Neuropace Inc.
    • Nevro Corporation
    • electroCore, Inc.
    • Axonics, Inc.
    • Nalu Medical
    • Mainstay Medical
    • Saluda Medical Pty Ltd
    • Biotronik
    • MicroTransponder Inc.
    • tVNS Technologies GmbH
    • Laborie
Product Code: 978-1-68038-066-8

Neurostimulation Devices Market Summary

The global neurostimulation devices market size was estimated at USD 5.80 billion in 2024 and is projected to reach USD 13.93 billion by 2033, growing at a CAGR of 10.29% from 2025 to 2033. The growth of the market is attributed due to the rising prevalence of neurological disorders, growing preference for minimally invasive therapies, and increasing demand for long-term pain management solutions.

Technological advancements such as closed-loop stimulation, MRI-compatible devices, and improved battery life enhance treatment precision and patient outcomes, driving wider clinical acceptance. In addition, expanding applications of neurostimulation in conditions such as chronic pain, epilepsy, Parkinson's disease, depression, and spinal cord injuries, along with supportive reimbursement policies in many regions, are further accelerating market growth.

Growing government funding for neuroscience research is a key driver of the neurostimulation devices market, as it accelerates the development of advanced neurostimulation technologies and expands therapeutic applications. By allocating capital to research programs, clinical trials, and innovation initiatives, governments enable a deeper understanding of neurological disorders and support breakthroughs in treatment approaches using neurostimulation. This financial backing fosters collaboration among researchers, clinicians, and medical device developers and encourages the commercialization of next-generation systems with improved safety, precision, and patient outcomes. Furthermore, government initiatives aimed at enhancing healthcare accessibility and reducing the cost burden of neurological care indirectly promote the adoption of neurostimulation therapies, expanding their reach to a broader patient base and fueling overall market growth.

Global Neurostimulation Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global neurostimulation devices market report on the basis of product, application, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Gastric Electrical Stimulation
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Parkinson's Disease
  • Chronic Pain
  • Migraine
  • Epilepsy
  • Tremor
  • Depression
  • Urinary & Fecal Incontinence
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Ambulatory Surgery Centers (ASC)
  • Clinics & Physiotherapy Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
    • 1.5.1. Data for primary interviews in North America
    • 1.5.2. Data for primary interviews in Europe
    • 1.5.3. Data for primary interviews in Asia Pacific
    • 1.5.4. Data for primary interviews in Latin America
    • 1.5.5. Data for Primary interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neurostimulation Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Government funding for research and development
      • 3.2.1.2. Technological advancements in neurostimulation devices
      • 3.2.1.3. Increasing prevalence of neurological disorders
      • 3.2.1.4. Growing reimbursement coverage
      • 3.2.1.5. Expanding applications
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Complex regulatory framework
      • 3.2.2.2. Surgery-associated risk
  • 3.3. Neurostimulation Devices Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. Neurostimulation Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Neurostimulation Devices Market: Product Movement Analysis, 2024 & 2033 (USD Million)
  • 4.3. Global Neurostimulation Devices Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Spinal Cord Stimulators
    • 4.4.1. Spinal cord stimulators market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Deep Brain Stimulators
    • 4.5.1. Deep brain stimulators market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Sacral Nerve Stimulators
    • 4.6.1. Sacral nerve stimulators market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Vagus Nerve Stimulators
    • 4.7.1. Vagus nerve stimulators market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.8. Gastric Electrical Stimulation
    • 4.8.1. Gastric electrical stimulation market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.9. Others
    • 4.9.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Neurostimulation Devices Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Neurostimulation Devices Market: Application Movement Analysis, 2024 & 2033 (USD Million)
  • 5.3. Global Neurostimulation Devices Market Size & Trend Analysis, by Application 2021 to 2033 (USD Million)
  • 5.4. Parkinson's Disease
    • 5.4.1. Parkinson's disease market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Chronic Pain
    • 5.5.1. Chronic pain market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Migraine
    • 5.6.1. Migraine market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Epilepsy
    • 5.7.1. Epilepsy market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.8. Tremor
    • 5.8.1. Tremor market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.9. Depression
    • 5.9.1. Depression market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.10. Urinary & Fecal Incontinence
    • 5.10.1. Urinary & fecal incontinence market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.11. Others
    • 5.11.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Neurostimulation Devices Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Neurostimulation Devices Market: End use Movement Analysis, 2024 & 2033 (USD Million)
  • 6.3. Global Neurostimulation Devices Market Size & Trend Analysis, by End use 2021 to 2033 (USD Million)
  • 6.4. Hospitals & Ambulatory Surgery Centers (ASC)
    • 6.4.1. Hospitals & Ambulatory Surgery Centers (ASC) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Clinics & Physiotherapy Centers
    • 6.5.1. Clinics & physiotherapy centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Neurostimulation Devices Market: Regional Estimates & Trend Analysis by Product, Application and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size and Trend Analysis, 2021 to 2033
  • 7.3. North America
    • 7.3.1. North America neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Competitive scenario
      • 7.3.2.3. Regulatory framework
      • 7.3.2.4. Reimbursement scenario
      • 7.3.2.5. U.S. neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Competitive scenario
      • 7.3.3.3. Regulatory framework
      • 7.3.3.4. Reimbursement scenario
      • 7.3.3.5. Canada neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Competitive scenario
      • 7.3.4.3. Regulatory framework
      • 7.3.4.4. Reimbursement scenario
      • 7.3.4.5. Mexico neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Competitive scenario
      • 7.4.2.3. Regulatory framework
      • 7.4.2.4. Reimbursement scenario
      • 7.4.2.5. UK neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Competitive scenario
      • 7.4.3.3. Regulatory framework
      • 7.4.3.4. Reimbursement scenario
      • 7.4.3.5. Germany neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Competitive scenario
      • 7.4.4.3. Regulatory framework
      • 7.4.4.4. Reimbursement scenario
      • 7.4.4.5. France neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Competitive scenario
      • 7.4.5.3. Regulatory framework
      • 7.4.5.4. Reimbursement scenario
      • 7.4.5.5. Italy neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Competitive scenario
      • 7.4.6.3. Regulatory framework
      • 7.4.6.4. Reimbursement scenario
      • 7.4.6.5. Spain neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Competitive scenario
      • 7.4.7.3. Regulatory framework
      • 7.4.7.4. Reimbursement scenario
      • 7.4.7.5. Sweden neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Competitive scenario
      • 7.4.8.3. Regulatory framework
      • 7.4.8.4. Reimbursement scenario
      • 7.4.8.5. Denmark neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Competitive scenario
      • 7.4.9.3. Regulatory framework
      • 7.4.9.4. Reimbursement scenario
      • 7.4.9.5. Norway neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. China neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Japan
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Japan neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Competitive scenario
      • 7.5.4.3. Regulatory framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. India neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Competitive scenario
      • 7.5.5.3. Regulatory framework
      • 7.5.5.4. Reimbursement scenario
      • 7.5.5.5. South Korea neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Competitive scenario
      • 7.5.6.3. Regulatory framework
      • 7.5.6.4. Reimbursement scenario
      • 7.5.6.5. Australia neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Competitive scenario
      • 7.5.7.3. Regulatory framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. Thailand neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Brazil neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. Argentina neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7. Middle East and Africa
    • 7.7.1. Middle East and Africa neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. South Africa neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Saudi Arabia neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. UAE neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. Kuwait neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Market Share Analysis, 2023
  • 8.4. Company Heat Map Analysis
  • 8.5. Strategy Mapping
    • 8.5.1. Expansion
    • 8.5.2. Mergers & Acquisition
    • 8.5.3. Partnerships & Collaborations
    • 8.5.4. New Product Launches
    • 8.5.5. Research And Development
    • 8.5.6. Company Profiles
    • 8.5.7. Abbott (St. Jude Medical)
      • 8.5.7.1. Company overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Medtronic
      • 8.5.8.1. Company overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Boston Scientific Corporation
      • 8.5.9.1. Company overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Aleva Neurotherapeutics
      • 8.5.10.1. Company overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic initiatives
    • 8.5.11. Nexstim
      • 8.5.11.1. Company overview
      • 8.5.11.2. Financial performance
      • 8.5.11.3. Product Benchmarking
      • 8.5.11.4. Strategic initiatives
    • 8.5.12. LivaNova PLC
      • 8.5.12.1. Company overview
      • 8.5.12.2. Financial performance
      • 8.5.12.3. Product Benchmarking
      • 8.5.12.4. Strategic initiatives
    • 8.5.13. Neuropace Inc.
      • 8.5.13.1. Company overview
      • 8.5.13.2. Financial performance
      • 8.5.13.3. Product Benchmarking
      • 8.5.13.4. Strategic initiatives
    • 8.5.14. Nevro Corporation
      • 8.5.14.1. Company overview
      • 8.5.14.2. Financial performance
      • 8.5.14.3. Product Benchmarking
      • 8.5.14.4. Strategic initiatives
    • 8.5.15. electroCore, Inc.
      • 8.5.15.1. Company overview
      • 8.5.15.2. Financial performance
      • 8.5.15.3. Product Benchmarking
      • 8.5.15.4. Strategic initiatives
    • 8.5.16. Axonics, Inc.
      • 8.5.16.1. Company overview
      • 8.5.16.2. Financial performance
      • 8.5.16.3. Product Benchmarking
      • 8.5.16.4. Strategic initiatives
    • 8.5.17. Nalu Medical
      • 8.5.17.1. Company overview
      • 8.5.17.2. Financial performance
      • 8.5.17.3. Product Benchmarking
      • 8.5.17.4. Strategic initiatives
    • 8.5.18. Mainstay Medical
      • 8.5.18.1. Company overview
      • 8.5.18.2. Financial performance
      • 8.5.18.3. Product Benchmarking
      • 8.5.18.4. Strategic initiatives
    • 8.5.19. Saluda Medical Pty Ltd
      • 8.5.19.1. Company overview
      • 8.5.19.2. Financial performance
      • 8.5.19.3. Product Benchmarking
      • 8.5.19.4. Strategic initiatives
    • 8.5.20. Biotronik
      • 8.5.20.1. Company overview
      • 8.5.20.2. Financial performance
      • 8.5.20.3. Product Benchmarking
      • 8.5.20.4. Strategic initiatives
    • 8.5.21. MicroTransponder Inc.
      • 8.5.21.1. Company overview
      • 8.5.21.2. Financial performance
      • 8.5.21.3. Product Benchmarking
      • 8.5.21.4. Strategic initiatives
    • 8.5.22. tVNS Technologies GmbH
      • 8.5.22.1. Company overview
      • 8.5.22.2. Financial performance
      • 8.5.22.3. Product Benchmarking
      • 8.5.22.4. Strategic initiatives
    • 8.5.23. Laborie
      • 8.5.23.1. Company overview
      • 8.5.23.2. Financial performance
      • 8.5.23.3. Product Benchmarking
      • 8.5.23.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America neurostimulation devices market, by region 2021 - 2033 (USD Million)
  • Table 3 North America neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 4 North America neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 5 North America neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 6 U.S. neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 7 U.S. neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 8 U.S. neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 9 Canada neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 10 Canada neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 11 Canada neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 12 Mexico neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 13 Mexico neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 14 Mexico neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 15 Europe neurostimulation devices market, by region 2021 - 2033 (USD Million)
  • Table 16 Europe neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 17 Europe neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 18 Europe neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 19 Germany neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 20 Germany neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 21 Germany neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 22 UK neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 23 UK neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 24 UK neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 25 France neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 26 France neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 27 France neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 28 Italy neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 29 Italy neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 30 Italy neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 31 Spain neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 32 Spain neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 33 Spain neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 34 Denmark neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 35 Denmark neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 36 Denmark neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 37 Sweden neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 38 Sweden neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 39 Sweden neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 40 Norway neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 41 Norway neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 42 Norway neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 43 Asia Pacific neurostimulation devices market, by region 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 47 China neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 48 China neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 49 China neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 50 Japan neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 51 Japan neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 52 Japan neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 53 India neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 54 India neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 55 India neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 56 South Korea neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 57 South Korea neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 58 South Korea neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 59 Australia neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 60 Australia neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 61 Australia neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 62 Thailand neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 63 Thailand neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 64 Thailand neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 65 Latin America neurostimulation devices market, by region 2021 - 2033 (USD Million)
  • Table 66 Latin America neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 67 Latin America neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 68 Latin America neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 69 Brazil neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 70 Brazil neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 71 Brazil neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 72 Argentina neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 73 Argentina neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 74 Argentina neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 75 MEA neurostimulation devices market, by region 2021 - 2033 (USD Million)
  • Table 76 MEA neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 77 MEA neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 78 MEA neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 79 South Africa neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 80 South Africa neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 81 South Africa neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 82 Saudi Arabia neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 85 UAE neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 86 UAE neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 87 UAE neurostimulation devices market, by end use 2021 - 2033 (USD Million)
  • Table 88 Kuwait neurostimulation devices market, by product 2021 - 2033 (USD Million)
  • Table 89 Kuwait neurostimulation devices market, by application 2021 - 2033 (USD Million)
  • Table 90 Kuwait neurostimulation devices market, by end use 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Neurostimulation devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Data analysis models
  • Fig. 5 Market formulation and validation
  • Fig. 6 Data validating & publishing
  • Fig. 7 Market snapshot
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Neurostimulation devices - market size and growth prospects (USD Million)
  • Fig. 11 Neurostimulation devices market: Industry Value Chain Analysis
  • Fig. 12 Neurostimulation devices market: Market Dynamics
  • Fig. 13 Neurostimulation devices market: PORTER's Analysis
  • Fig. 14 Neurostimulation devices market: PESTEL Analysis
  • Fig. 15 Neurostimulation devices market share by product, 2024 & 2033 (USD Million)
  • Fig. 16 Neurostimulation devices market, by product: market share, 2024 & 2033
  • Fig. 17 Spinal cord stimulators market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 18 Deep brain stimulators market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 19 Sacral nerve stimulators market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 20 Vagus nerve stimulators market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 21 Gastric electrical stimulation market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 22 Others market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 23 Neurostimulation devices market share by application, 2024 & 2033 (USD Million)
  • Fig. 24 Neurostimulation devices market, by application: market share, 2024 & 2033
  • Fig. 25 Parkinson's disease market share by application, 2024 & 2033 (USD Million)
  • Fig. 26 Chronic Pain market share by application, 2024 & 2033 (USD Million)
  • Fig. 27 Migraine market share by application, 2024 & 2033 (USD Million)
  • Fig. 28 Epilepsy market share by application, 2024 & 2033 (USD Million)
  • Fig. 29 Tremor market share by application, 2024 & 2033 (USD Million)
  • Fig. 30 Depression market share by application, 2024 & 2033 (USD Million)
  • Fig. 31 Neurostimulation devices market share by application, 2024 & 2033 (USD Million)
  • Fig. 32 Others market share by application, 2024 & 2033 (USD Million)
  • Fig. 33 Neurostimulation devices market share by end use, 2024 & 2033 (USD Million)
  • Fig. 34 Neurostimulation devices market, by end use: market share, 2024 & 2033
  • Fig. 35 Hospitals & Ambulatory Surgery Centers (ASC) market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 36 Clinics & physiotherapy centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 37 Others market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 38 Regional marketplace: key takeaways
  • Fig. 39 North America neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 US neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Canada neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Mexico neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Europe neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 UK neurostimulation devices market estimates and forecasts, 2021 - 2033,) (USD Million)
  • Fig. 45 Germany neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 46 France neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 47 Italy neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 48 Spain neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 49 Sweden neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 50 Denmark neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 51 Norway neurostimulation devices market estimates and forecasts (2021 - 2033,) (USD Million)
  • Fig. 52 Asia Pacific neurostimulation devices market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 53 China neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Japan neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 India neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 South Korea neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Australia neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Thailand neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Latin America neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Brazil neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Argentina neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 MEA neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 South Africa neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Saudi Arabia neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 UAE neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Kuwait neurostimulation devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key company categorization
  • Fig. 68 Company market positioning
  • Fig. 69 Key company market share analysis, 2023
  • Fig. 70 Strategic framework